Dan Dean

Non-Hodgkin lymphoma survivor
Authored Items
October 2019 Vol 5 No 5
At the June 2019 annual meeting of the American Society of Clinical Oncology (ASCO), 2 experts discussed the implications of new treatments for chronic lymphocytic leukemia (CLL). The blood cancer known as CLL is often diagnosed late, and until recently the initial treatment was chemotherapy alone. However, new non-chemotherapy targeted therapies have been approved by the FDA in the past few months for use as the first (or first-line) treatment for patients with CLL.
February 2019 Vol 5 No 1
Cancer survivor Dan Dean weighs the many factors involved when deciding what to tell, or not tell, an employer about a cancer diagnosis and the job-related potential implications.
August 2018 Vol 4 No 4
People affected by cancer find that dating requires a different playbook to navigate through relationships.
February 2018 Vol 4 No 1
The long-term side effects of treatment can be an overlooked part of cancer care. "We're learning as they're surviving, and we can't assume we know everything," says Pam Simon, MSN.
August 2017 Vol 3 No 4
Non-Hodgkin lymphoma survivor Dan Dean tackles the stigmas and difficulties associated with mental health diagnoses and therapies.
February 2017 Vol 3 No 1
Survivorship can feel like a game of cancer whack-a-mole: pound one issue flat and another pops up, often where you weren’t even looking.
Last modified: September 26, 2018